EUVIMEDEUVIMED entdecken
Crossref

A network pharmacology approach to investigate dehydrocostus lactone inhibits the proliferation and epithelial-mesenchymal transition of human gastric cancer cells via regulating the PI3K/Akt and extracellular signal-regulated kinases/mitogen-activated protein kinase signalling pathways

Meiqi Wan, Jun Dai, Anna Gan, Jinyu Wang, Fei Lin, Xiaoying Zhang, Xinyan Lv, Bo Wu, Tingxu Yan, Ying Jia iD

Journal of Pharmacy and Pharmacology · 2023

DOI: 10.1093/jpp/rgad065 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2023. Verfasst von Meiqi Wan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Functional Food and Wine, Shenyang Pharmaceutical University, Shenyang, China. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Stomach Neoplasms, Sesquiterpenes, Cell Proliferation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Laboratory of Polysaccharide Bioactivity Evaluation of TCM of Liaoning Province, High-level innovation and entrepreneurship team of Liaoning Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Dehydrocostus lactone (DHE), a sesquiterpene lactone, has been proven the significant inhibition of multiple cancer cells. However, there are limited reports on the activity of DHE in gastric cancer (GC). In this research, Network pharmacology predicted the anti-GC mechanism of DHE, and the prediction was verified by in-vitro experiments.

Methods

Network pharmacology confirmed the major effect signalling pathway of DHE in treating GC. Cell viability assay, colony formation assay, wound healing assay, cell migration and invasion assay, apoptosis assay, western blot and real-time quantitative polymerase chain reaction verified the mechanism of DHE in GC cell lines. Key findings The results showed that DHE inhibited the growth and metastasis of MGC803 and AGS GC cells. Mechanistically, the analysis results indicated that DHE significantly induced the apoptosis process by suppressing the PI3K/protein kinase B (Akt) signalling pathway, and inhibited epithelial-mesenchymal transition by suppressing the extracellular signal-regulated kinases (ERK)/MAPK signalling pathway. The Akt activator (SC79) inhibited DHE induced apoptosis, and DHE had similar effects with the ERK inhibitor (FR180204).

Conclusions

All results suggested that DHE was a potential natural chemotherapeutic drug in GC treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epithelial-Mesenchymal TransitionStomach NeoplasmsSesquiterpenesCell ProliferationLactonesAntineoplastic Agents, PhytogenicHumansCell Line, TumorProto-Oncogene Proteins c-aktNetwork PharmacologyApoptosisPhosphatidylinositol 3-KinasesCell MovementSignal TransductionMAP Kinase Signaling SystemExtracellular Signal-Regulated MAP KinasesCell Survival

Stichwörter der Autor:innen

apoptosisdehydrocostus lactoneepithelial-mesenchymal transitiongastric cancernetwork pharmacology

Substanzen

SesquiterpenesProto-Oncogene Proteins c-aktLactonesdehydrocostus lactonePhosphatidylinositol 3-KinasesExtracellular Signal-Regulated MAP KinasesAntineoplastic Agents, Phytogenic

Autor:innen und Institutionen

  • Faculty of Functional Food and Wine, Shenyang Pharmaceutical University, Shenyang, China.
  • School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, China.

ORCID-Profile: Ying Jia

Förderung

  • National Natural Science Foundation of China
  • Key Laboratory of Polysaccharide Bioactivity Evaluation of TCM of Liaoning Province
  • High-level innovation and entrepreneurship team of Liaoning Province
  • Liaoning Provincial Department of Education Fund

Zitieren

APA

Wan, M., Dai, J., Gan, A., Wang, J., Lin, F., Zhang, X., Lv, X., Wu, B., Yan, T., & Jia, Y. (2023). A network pharmacology approach to investigate dehydrocostus lactone inhibits the proliferation and epithelial-mesenchymal transition of human gastric cancer cells via regulating the PI3K/Akt and extracellular signal-regulated kinases/mitogen-activated protein kinase signalling pathways. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgad065

Vancouver

Wan M, Dai J, Gan A, Wang J, Lin F, Zhang X, et al. A network pharmacology approach to investigate dehydrocostus lactone inhibits the proliferation and epithelial-mesenchymal transition of human gastric cancer cells via regulating the PI3K/Akt and extracellular signal-regulated kinases/mitogen-activated protein kinase signalling pathways. Journal of Pharmacy and Pharmacology. 2023. doi:10.1093/jpp/rgad065

BibTeX
@article{Wan2023,
  author = {Wan, Meiqi and Dai, Jun and Gan, Anna and Wang, Jinyu and Lin, Fei and Zhang, Xiaoying and Lv, Xinyan and Wu, Bo and Yan, Tingxu and Jia, Ying},
  title = {A network pharmacology approach to investigate dehydrocostus lactone inhibits the proliferation and epithelial-mesenchymal transition of human gastric cancer cells via regulating the PI3K/Akt and extracellular signal-regulated kinases/mitogen-activated protein kinase signalling pathways},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2023},
  doi = {10.1093/jpp/rgad065}
}
Kostenlos starten →